Atlas Trials

X4 Pharmaceuticals

12 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch X4 Pharmaceuticals

RecordFirmDate
A Study to Investigate Pharmacokinetics (PK) and Safety of a Single Dose of Mavorixafor in Participants With Hepatic Impairment (HI) Compared to Matched Healthy Volunteers With Normal Hepatic Function (NCT06858696)X4 Pharmaceuticals2025-02-28
Drug-Drug Interaction Potential of Mavorixafor (NCT06914869)X4 Pharmaceuticals2025-02-18
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections (NCT06056297)X4 Pharmaceuticals2024-06-06
A Study of Mavorixafor in Participants With Congenital Neutropenia and Chronic Idiopathic Neutropenia Disorders (NCT04154488)X4 Pharmaceuticals2021-10-16
A Study of Mavorixafor in Combination With Ibrutinib in Participants With Waldenstrom's Macroglobulinemia (WM) Whose Tumors Express Mutations in MYD88 and CXCR4 (NCT04274738)X4 Pharmaceuticals2020-04-30
Efficacy and Safety Study of Mavorixafor in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome (NCT03995108)X4 Pharmaceuticals2019-10-24

Track X4 Pharmaceuticals automatically

Every clearance here is in the API, with alerts when new ones post.